The U.S. anti-snoring devices and snoring surgery market was surpassed at USD 483.75 million in 2022 and is expected to hit around USD 910.63 million by 2032, growing at a CAGR of 6.53% from 2023 to 2032.
Key Pointers
The rising prevalence of obesity, the easy availability of products through offline and online channels in the U.S., and the launch of technologically advanced products are the major factors boosting the growth of the U.S. anti-snoring devices and snoring surgery market.
The COVID-19 pandemic had a major impact on the U.S. in every aspect, from healthcare to the economy, everything was severely affected. The pandemic led to a fall in sales of anti-snoring devices due to reduced patient visits to dentists. In addition, the lockdowns and restrictions on movement by the government severely disrupted the demand and supply chain which also contributed to a drop in sales of the devices during the pandemic.
Moreover, the pandemic also led to the postponement or cancellation of elective surgeries in order to avoid the spread of the virus. Many individuals also opted to willingly postpone their surgeries and avoid hospital visits, in order to avoid being infected with the virus. All these factors indicated that the pandemic had far-reaching effects on the industry. However, with the opening of economies and the world returning to normalcy, the market quickly gained traction and managed to recover at a very swift pace post-pandemic. Furthermore, with the launch of new products in the market, it is expected to grow exponentially over the forecast period as well.
Increasing prevalence of obesity is one of the major factors driving the demand for anti-snoring devices and snoring surgery devices. This is due to the increasing consumption of fast-food, and reduced physical activity which represents a growing shift towards a sedentary lifestyle among U.S. citizens. For instance, according to CDC, the U.S. obesity prevalence between the years 2019 to 2020 was 41.9%.
Obesity related problems include stroke, type 2 diabetes, heart disease, and certain types of cancer which are among the leading cause of premature preventable death. Additionally, the incidence of snoring and sleep apnea is also acute among individuals who are obese. In addition, the easy availability of these products in retail stores as well as through online sales is also a factor influencing the growth of the market. Moreover, the rise in the number of customers being inclined towards e-commerce and a wide variety of options on e-commerce sites is also helping the market to grow and will further accelerate over the forecast period.
Key Companies & Market Share Insights
Key players in the U.S. anti-snoring devices and snoring surgery market are focusing on carrying out various strategic initiatives in order to secure a strong position in the market. Some of the key strategic initiatives carried out include acquisition & mergers, partnership & collaboration, new product launches, etc. For instance, in February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA, and the device works by producing electrical muscle stimulation through a mouthpiece around the tongue. Some prominent players in the U.S. anti-snoring devices and snoring surgery market include:
U.S. Anti-snoring Devices And Snoring Surgery Market Segmentations:
By Type
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on U.S. Anti-snoring Devices And Snoring Surgery Market
5.1. COVID-19 Landscape: U.S. Anti-snoring Devices And Snoring Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. U.S. Anti-snoring Devices And Snoring Surgery Market, By Type
8.1.U.S. Anti-snoring Devices And Snoring Surgery Market, by Type Type, 2023-2032
8.1.1. Oral appliances/Mouthpieces
8.1.1.1.Market Revenue and Forecast (2020-2032)
8.1.2. Nasal Devices
8.1.2.1.Market Revenue and Forecast (2020-2032)
8.1.3. Position Control Devices
8.1.3.1.Market Revenue and Forecast (2020-2032)
8.1.4. Chin Straps
8.1.4.1.Market Revenue and Forecast (2020-2032)
8.1.5. Tongue Stabilizing Devices
8.1.5.1.Market Revenue and Forecast (2020-2032)
8.1.6. EPAP Therapy Devices
8.1.6.1.Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Anti-snoring Devices And Snoring Surgery Market, Regional Estimates and Trend Forecast
9.1. U.S.
9.1.1. Market Revenue and Forecast, by Type (2020-2032)
Chapter 10.Company Profiles
10.1. Ocular Therapeutix Inc.
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2. SomnoMed Ltd.
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3. Airway Management, Inc.
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4. Resmed Inc.
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5. Fisher & Paykel Healthcare Corp. Ltd.
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6. Koninklijke Philips NV
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
10.7. Sleep Well Enjoy Life, Ltd.
10.7.1.Company Overview
10.7.2.Product Offerings
10.7.3.Financial Performance
10.7.4.Recent Initiatives
10.8. Tomed Dr. Toussaint GmbH
10.8.1.Company Overview
10.8.2.Product Offerings
10.8.3.Financial Performance
10.8.4.Recent Initiatives
10.9. MEDiTAS Ltd.
10.9.1.Company Overview
10.9.2.Product Offerings
10.9.3.Financial Performance
10.9.4.Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1. About Us
12.2. Glossary of Terms